Century Therapeutics IPSC
NASDAQ IPSC
$1.53 -0.08 (-4.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Century Therapeutics' Return on Capital Employed [ROCE] was -40.10% in Q2 2026, down 28.69 percentage points from -11.42% a year earlier but up 3.91 percentage points from the prior quarter.

Analysis

Century Therapeutics (IPSC) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Century Therapeutics came in at -6.44%, up 54.37 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of +30.56 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -60.81% in FY2024 (-24.69 pp), -36.12% in FY2023 (-5.15 pp), -30.97% in FY2022 (+6.03 pp) and -37.00% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -57.29% (Q4 2024) and -8.07% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of +6.58 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 49.22 percentage points); the worst was Q1 2026 (a drop of 33.81 percentage points).
  • Per Business Quant data, IPSC's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -44.01% (Q1 2026), -8.07% (Q4 2025) and -13.97% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Century Therapeutics 276.24 Mn -228.14 Mn - -40.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.10%
Mar 31, 2026 -44.01%
Dec 31, 2025 -8.07%
Sep 30, 2025 -13.97%
Jun 30, 2025 -11.42%
Mar 31, 2025 -10.21%
Dec 31, 2024 -57.29%
Sep 30, 2024 -37.79%
Jun 30, 2024 -40.03%
Mar 31, 2024 -43.06%
Dec 31, 2023 -40.56%
Sep 30, 2023 -35.17%
Jun 30, 2023 -31.66%
Mar 31, 2023 -28.96%
Dec 31, 2022 -28.52%
Sep 30, 2022 -25.95%
Jun 30, 2022 -23.58%
Mar 31, 2022 -24.21%
Dec 31, 2021 -21.67%
Sep 30, 2021 -17.75%
API Access

Century Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IPSC&period=max&api_key=YOUR_API_KEY